ZipRecruiter

Log In

1

Biotechnology Investment Analyst Jobs (NOW HIRING)

T Rowe Price

Biotech Associate

Baltimore, MD · Hybrid

Diverse responsibilities on the biotechnology investment team, including analyzing preclinical and clinical data across all therapeutic areas, accessing market potential, and developing financial ...

HighVista Strategies LLC

Analyst, Biotechnology

Boston, MA · On-site

$110K - $140K/yr

This analyst will support the Biotechnology Research efforts the firm has a 13-year history of investing in, with a strong track record of outperformance. The primary responsibilities of the role ...

T Rowe Price

Bio Tech Associate

Baltimore, MD · Hybrid

Diverse responsibilities on the biotechnology investment team, including analyzing preclinical and clinical data across all therapeutic areas, accessing market potential, and developing financial ...

Tang Capital

Biotechnology Research Analyst

Manhattan, NY · On-site

$120K - $210K/yr

... focused investment firm with offices in San Diego and New York. Position Summary Tang Capital is ... The Analyst will support scientific, clinical, and strategic analyses across biotechnology assets ...

Tang Capital

Biotechnology Research Analyst

Manhattan, NY · On-site

$120K - $210K/yr

... focused investment firm with offices in San Diego and New York. Position Summary Tang Capital is ... The Analyst will support scientific, clinical, and strategic analyses across biotechnology assets ...

next page

Showing results 1-20

All JobsFinance and Insurance JobsFinancial Services JobsFinancial Analyst JobsBiotechnology Investment Analyst Jobs

Biotechnology Investment Analyst information

See salary details

$35K

$85.8K

$133K

How much do biotechnology investment analyst jobs pay per year?

As of Aug 26, 2026, the average yearly pay for biotechnology investment analyst in the United States is $85,807.00, according to ZipRecruiter salary data. Most workers in this role earn between $66,500.00 and $99,500.00 per year, depending on experience, location, and employer.

What does a biotechnology investment analyst do?

A Biotechnology Investment Analyst researches and evaluates companies in the biotech sector to provide investment recommendations. They analyze financial statements, scientific data, clinical trial results, and market trends to assess the potential risks and returns of biotech stocks or assets. Their work helps investors make informed decisions about where to allocate capital in the rapidly evolving biotechnology industry. Analysts often prepare detailed reports, monitor industry developments, and meet with company executives or scientists to gain deeper insights.

What are the key skills and qualifications needed to thrive as a biotechnology investment analyst, and why are they important?

To thrive as a Biotechnology Investment Analyst, you need a solid background in life sciences or finance, often supported by degrees such as a PhD, MD, or MBA, and strong analytical abilities. Familiarity with financial modeling tools, data analysis platforms like Excel or Bloomberg, and understanding of regulatory databases is crucial. Exceptional communication, critical thinking, and the ability to distill complex scientific data for investment decisions help set top analysts apart. These combined skills are vital for accurately evaluating biotechnology companies, identifying investment opportunities, and conveying insights to stakeholders in a dynamic and high-risk sector.

What are some typical challenges biotechnology investment analysts face when evaluating potential investment opportunities?

Biotechnology Investment Analysts often encounter challenges such as assessing early-stage companies with limited financial histories, understanding complex scientific data, and staying updated on rapidly evolving industry trends. Working closely with scientists and business leaders, analysts must bridge technical and financial perspectives to make informed recommendations. Additionally, navigating regulatory uncertainties and market volatility requires strong analytical skills and adaptability.

What is the difference between Biotechnology Investment Analyst vs Biotech Research Associate?

AspectBiotechnology Investment AnalystBiotech Research Associate
Required CredentialsDegree in finance, biology, or related field; often CFA or similar certificationsDegree in biology, biochemistry, or related scientific field; advanced degrees preferred
Work EnvironmentFinancial firms, investment banks, or venture capital firmsResearch labs, biotech companies, academic institutions
Employer & Industry UsageFinancial industry focusing on biotech investmentsBiotech and pharmaceutical research sectors
Common Search & Comparison IntentUnderstanding financial analysis and investment roles in biotechUnderstanding scientific research roles in biotech

The main difference between a Biotechnology Investment Analyst and a Biotech Research Associate lies in their focus and work environment. The analyst evaluates biotech companies for investment purposes, requiring finance and industry knowledge, while the research associate conducts scientific experiments and supports research projects within biotech labs. Both roles are essential in the biotech industry but serve different functions and career paths.

More about Biotechnology Investment Analyst jobs

What states have the most Biotechnology Investment Analyst jobs?

States with the most job openings for Biotechnology Investment Analyst jobs include:

What job categories do people searching Biotechnology Investment Analyst jobs look for?

The top searched job categories for Biotechnology Investment Analyst jobs are:

Biotechnology Investment Analyst jobs near you
Infographic showing various Biotechnology Investment Analyst job openings in the United States as of August 2026, with employment types broken down into 92% Full Time, 6% Part Time, and 2% Contract. Highlights an 85% Physical, 6% Hybrid, and 9% Remote job distribution, with an average salary of $85,807 per year, or $41.3 per hour.

Biotech Investment Analyst - Specialist Fund

Mercor

New York, NY • Remote

$125 - $200/hr

Full-time

Posted 17 days ago

Job description

About the job

Mercor connects elite creative and technical talent with leading AI research labs. Headquartered in San Francisco, our investors include Benchmark, General Catalyst, Peter Thiel, Adam D'Angelo, Larry Summers, and Jack Dorsey.

Position: Biotech Investment Analyst — Drug Asset & Company Assessment
Type: Contract
Compensation: $125–$200/hour
Location: Remote
Duration: 1–2 week pilot

Role Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs.
  • Provide overall company and asset assessment, including mechanism, clinical data, competitive position, and value drivers.
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions.
  • Apply your assessment across the pilot's set of companies, approximately 5–10.
  • Work independently and asynchronously to meet deadlines while improving AI model performance.

Qualifications

Must-Have

  • US-based biotech/healthcare investment analyst with a specialist-fund background.
  • Familiarity with biotech/pharma development programs.
  • Able to assess a drug asset and the company behind it end-to-end.
  • 5+ years evaluating biotech/pharma companies or assets.

Compensation & Legal

  • Hourly contractor

Application Process (Takes 20–30 mins to complete)

  • Upload resume
  • AI interview based on your resume
  • Submit form

Resources & Support

  • For details about the interview process and platform information, please check: https://talent.docs.mercor.com/welcome
  • For any help or support, reach out to: support@mercor.com

PS: Our team reviews applications daily. Please complete your AI interview and application steps to be considered for this opportunity.